The Silent Threat in Cell Therapy Development: Transient Warming Events
Protecting Cell Therapy Quality by Preventing Transient Warming Events As cell and gene therapies continue to gain traction, the industry’s focus on automation, digital transformation, and advanced manufacturing platforms is stronger than ever. But in the midst of these innovations, one often overlooked challenge can quietly compromise therapy outcomes: Transient Warming Events (TWEs). At The […]
The Cell Summit ’25 Frequently Asked Questions (FAQs)
Everything You Need to Know Before The Cell Summit ’25 As we gear up for The Cell Summit ’25, we want to make sure you have all the details you need to plan your trip, navigate the event, and make the most of your time in Indianapolis. From hotel and shuttle logistics to what to […]
Meet the Makers: Innovations and Insights from The Cell Summit ’25
Voices from the Lab: Breakthroughs and Best Practices from The Cell Summit This August, leaders across the cell and gene therapy (CGT) industry will gather in Indianapolis for The Cell Summit ’25, hosted by BioLife Solutions. Designed as a dynamic forum for knowledge-sharing, product exploration, and problem-solving, this event brings together voices shaping the next […]
Designing the Ideal Cryostorage Container for CGT
Celebrating Innovation: The CellSeal CryoCase One Year Later Since its launch at the 2024 ISCT Annual Meeting, the CellSeal® CryoCase is poised to become a cornerstone solution for Cell and Gene Therapy (CGT) and biopharmaceutical storage. Designing this ideal cryostorage container involved precise engineering and deep industry understanding. This innovative design represents significant advancement in […]
The Cell Summit ’25: A Must-Attend Event for Innovators in Cell & Gene Therapy
Join the Premier Cell and Gene Therapy Manufacturing Summit of 2025 WHEN: August 5–6th WHERE: Newfields Art Museum, Indianapolis, IN In the ever-evolving field of cell and gene therapy, the pressure to scale, preserve, and commercialize cell-based products has never been greater. That’s why BioLife Solutions, Azenta Life Sciences, and Entegris have partnered to bring […]
CryoCase: Rethink the standard. Replace the bag.
Discover the groundbreaking CellSeal® CryoCase™, the first rigid primary container engineered for closed-system fluid processing in cell and gene therapy (CGT) applications. Launched in November 2024, the CryoCase offers unmatched fracture resistance, transparency for quality inspections, and automation-ready design, addressing the common pitfalls of traditional cryobags and cryovials. With proven performance in freeze-thaw processes and enhanced contamination control, CryoCase is revolutionizing CGT manufacturing workflows. Explore white papers, webinars, and case studies to see how CryoCase can transform your storage solutions. Learn more or request your test sample today!
How Does a Water-Free Automated Thawing System Improve Your Cryopreservation Process?
Cryopreservation has come a long way… Over the past 50 years, advances in biopreservation techniques have enabled industry-wide progress in a range of fields including cell biology research, drug discovery, biobanking, assisted reproduction, and even plant and animal conservation, with the fields of cellular therapy and regenerative medicine seeing the greatest expansion recently. As these […]
Overcoming Cryopreservation Challenges
Navigating the Challenges of Cryopreservation in Cell-Based Research Biopreservation, and specifically cryopreservation, is critical for maintaining the viability of cells long-term throughout storage and research. Recently, BioLife Solutions partnered with Cell and Gene Therapy Insights to produce a poster that highlights many of the challenges researchers face, balanced with Biopreservation Best Practice suggestions. To receive […]
The History of Cryopreservation
Cryopreservation: From Home-Brew to Cutting-Edge Solutions In the pursuit of medical breakthroughs, technology often emerges from the drive to fulfill critical needs. This is particularly evident in the field of cryopreservation, where a convergence of technological advances seeks to preserve therapeutic cells for a myriad of applications, from treating human afflictions to aiding animals in […]
Universal Cell Management System – What is it? and Why is it important to the Cell and Gene Therapy (CGT) Industry?
The Signata CT-5 is a Universal Cell Management System designed for cell and gene therapy production. It enhances efficiency and flexibility in key processes like final fill, media formulation, bioreactor fill, and cell culture wash. With its closed-automation and compatibility with a wide range of consumables, the CT-5 supports scalable, contamination-free cell therapy manufacturing.